These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13490)

  • 41. [Choice of drugs in the treatment of hypertension].
    Zacchello F
    Minerva Pediatr; 1977 Mar; 29(7):439-49. PubMed ID: 17061
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in the renin-angiotensin-aldosterone system during graduated ergometric tests in patients with essential arterial hypertension and in normal controls].
    Marchezotti AV; Feldstein CA; Leber B; Burucúa JE; Vilches AM; Varela de Rodríguez J
    Rev Clin Esp; 1981 May; 161(3):145-8. PubMed ID: 7022582
    [No Abstract]   [Full Text] [Related]  

  • 43. [Graduated plan for the treatment of hypertension].
    Zilcher H; Weber H; Polterauer P; Zasmeta H
    Med Klin; 1981 Sep; 76(20):568-9. PubMed ID: 6124874
    [No Abstract]   [Full Text] [Related]  

  • 44. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 45. [Practical medical treatment of essential hypertension].
    Ménard J; Corvol P; Bloch-Lainé JF; Milliez P
    Cah Med; 1973 Oct; 14(11):935-6 passim. PubMed ID: 4151120
    [No Abstract]   [Full Text] [Related]  

  • 46. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 47. Progress in the treatment of essential hypertension.
    Sharma PL; Pandhi P
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S54-61. PubMed ID: 2432023
    [No Abstract]   [Full Text] [Related]  

  • 48. [The characteristics of the antihypertensive treatment of diabetes mellitus patients].
    Glezer GA
    Ter Arkh; 1993; 65(10):32-4. PubMed ID: 7905207
    [No Abstract]   [Full Text] [Related]  

  • 49. [Renin, angiotensin II, catecholamines and blood pressure in healthy subjects and in patients with essential hypertension prior and following beta-blockade].
    Schuchard J; Dahlheim H; Wober W; Grill G; Lydtin H; Thurau K
    Verh Dtsch Ges Inn Med; 1974; 80():215-8. PubMed ID: 4156113
    [No Abstract]   [Full Text] [Related]  

  • 50. [Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment].
    Andrejak M; Fournier A; Hardin JM; Lambrey G; de Frémont JF; Coevoet B
    Coeur Med Interne; 1978; 17(3):381-400. PubMed ID: 31260
    [No Abstract]   [Full Text] [Related]  

  • 51. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
    [No Abstract]   [Full Text] [Related]  

  • 52. beta-Adrenergic blockade reduces the severity of acute renal failure in rats.
    Iaina A; Solomon S; Eliahou H
    Proc Eur Dial Transplant Assoc; 1976; 12():197-202. PubMed ID: 6958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: When to measure renin.
    Lancet; 1975 Apr; 1(7910):783-4. PubMed ID: 48006
    [No Abstract]   [Full Text] [Related]  

  • 54. Future trends in antihypertensive therapy.
    Missotten A; Amery A
    Acta Clin Belg; 1974; 29(5):262-9. PubMed ID: 4155217
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experience in the treatment of hypertensive states with beta-blockaders].
    Mikhaĭlov AA; Danil'chenko MA; Zakharova AV
    Kardiologiia; 1973 Jan; 13(1):70-5. PubMed ID: 4149112
    [No Abstract]   [Full Text] [Related]  

  • 56. [The pathogenesis and treatment of renovascular hypertension].
    Kusano E; Akai Y
    Nihon Rinsho; 1989 Sep; 47(9):2008-12. PubMed ID: 2574241
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta-adrenergic blockade, blood pressure, and the renin-angiotensin system.
    Gross F
    Eur J Clin Invest; 1977 Oct; 7(5):321-2. PubMed ID: 21795
    [No Abstract]   [Full Text] [Related]  

  • 58. Beta blockers for the treatment of primary hypertension.
    Cruickshank JM
    Lancet; 2006 Jan; 367(9506):209; author reply 210. PubMed ID: 16427487
    [No Abstract]   [Full Text] [Related]  

  • 59. Control of renin release: a review of experimental evidence and clinical implications.
    Zanchetti A; Stella A; Leonetti G; Morganti A; Terzoli L
    Am J Cardiol; 1976 Mar; 37(4):675-91. PubMed ID: 3964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
    Bühler FR; Burkart F; Lütold BE; Küng M; Marbet G; Pfisterer M
    Am J Cardiol; 1975 Oct; 36(5):653-69. PubMed ID: 242209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.